相关实验视频
Updated: Jul 5, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.7K
泌尿酸酶等离子素激活受体:慢性腹腔内血瘤的重要焦点参与者?
Thorbjørn Søren Rønn Jensen1, Markus Harboe Olsen2,3, Giedrius Lelkaitis4
1Department of Neurosurgery, The Neuroscience Center, Copenhagen University Hospital, Inge Lehmanns Vej 6, 2100, Rigshospitalet, Copenhagen, Denmark. tjens07@gmail.com.
Inflammation
|January 18, 2024
概括
这项研究确定了慢性腹腔内血瘤 (CSDH) 液体和膜中的尿素酶等离子酶激活剂受体 (uPAR). 在CSDH液体和膜中升高的UPAR水平表明它们在CSDH病变发生过程中的作用.
科学领域:
- 神经外科 神经外科
- 生物化学 生物化学
- 病理生理学 病理生理学
背景情况:
- 慢性腹腔内血瘤 (CSDH) 涉及复杂的炎症,血管新生和纤维溶解过程.
- 泌尿酸酶等离子体激活器受体 (uPAR) 因其在炎症,血管生成和纤维素分解中的作用而涉及到这些机制.
研究的目的:
- 在CSDH液体,膜,硬膜和全身血液中检测UPAR.
- 调查手术前PAR水平是否可以预测复发的CSDH.
主要方法:
- 免疫组织化学被用来分析PUPAR表达在血液瘤膜和硬质体中.
- 多重抗体珠套件 (Luminex) 量化了血瘤液和全身血液中的UPAR水平.
- 在最初的CSDH手术期间采集样本,并对复发病例进行重新采集.
主要成果:
- 在CSDH液体,膜,硬膜和全身血液中发现了UPAR.
- 与全身血液 (789 pg/L) 相比,血瘤液 (22,125 pg/L) 的中位数UPAR水平显著更高.
- 在血瘤膜 (H-分数14.3) 中,UPAR水平显著高于硬膜 (H-分数0.81).
结论:
- 这是第一个在各种CSDH相关组织和液体中识别UPAR的研究.
- 在皮下液体和血瘤膜中Upar的高表达突显了它们在CSDH发育中的核心作用.
- uPAR可能是CSDH背后的炎症和纤维素分析途径的关键因素.
相关概念视频
Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K
Coagulation
6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701

